Abecassis M - Search Results

1

Activation of the immune coagulation system by murine hepatitis virus strain 3.

Levy G, Abecassis M. Levy G, et al. Among authors: abecassis m. Rev Infect Dis. 1989 May-Jun;11 Suppl 4(Suppl 4):S712-21. doi: 10.1093/clinids/11.supplement_4.s712. Rev Infect Dis. 1989. PMID: 2546245 Free PMC article. Review.

2

Mechanism of protective effect of prostaglandin E in murine hepatitis virus strain 3 infection: effects on macrophage production of tumour necrosis factor, procoagulant activity and leukotriene B4.

Sinclair S, Abecassis M, Wong PY, Romaschin A, Fung LS, Levy G. Sinclair S, et al. Among authors: abecassis m. Adv Exp Med Biol. 1990;276:533-42. doi: 10.1007/978-1-4684-5823-7_74. Adv Exp Med Biol. 1990. PMID: 1966446 No abstract available.

3

Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.

Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, Cameron R, Levy GA. Sinclair SB, et al. Among authors: abecassis m. J Clin Invest. 1989 Oct;84(4):1063-9. doi: 10.1172/JCI114268. J Clin Invest. 1989. PMID: 2794044 Free PMC article.

4

Resistance to murine hepatitis virus strain 3 (MHV-3) infection in A/J mice is not affected by cyclosporin A (CsA).

Abecassis M, Falk J, Makowka L, Dindzans V, Falk R, Levy G. Abecassis M, et al. Adv Exp Med Biol. 1987;218:469-71. doi: 10.1007/978-1-4684-1280-2_60. Adv Exp Med Biol. 1987. PMID: 2829562 No abstract available.

5

Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals.

Abecassis M, Falk J, Dindzans V, Lopatin W, Makowka L, Levy G, Falk R. Abecassis M, et al. Transplant Proc. 1987 Feb;19(1 Pt 2):1103-5. Transplant Proc. 1987. PMID: 2856269 No abstract available.

6

Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.

Fingerote RJ, Abecassis M, Phillips MJ, Rao YS, Cole EH, Leibowitz J, Levy GA. Fingerote RJ, et al. Among authors: abecassis m. J Virol. 1996 Jul;70(7):4275-82. doi: 10.1128/JVI.70.7.4275-4282.1996. J Virol. 1996. PMID: 8676449 Free PMC article.

7

Delta and conjugated bilirubin as complementary markers of early rejection in liver-transplant recipients.

Wu TW, Levy GA, Yiu S, Au JX, Greig PD, Strasberg SM, Ettles M, Abecassis M, Superina RA, Langer B, et al. Wu TW, et al. Among authors: abecassis m. Clin Chem. 1990 Jan;36(1):9-14. Clin Chem. 1990. PMID: 2297940

8

Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ mice.

Abecassis M, Falk J, Dindzans V, Lopatin W, Makowka L, Levy G, Falk R. Abecassis M, et al. Adv Exp Med Biol. 1987;218:465-6. doi: 10.1007/978-1-4684-1280-2_58. Adv Exp Med Biol. 1987. PMID: 2829560 No abstract available.

9

Cyclosporine A fails to alter innate host resistance to murine hepatitis virus strain 3 infection in A/J mice.

Abecassis M, Falk J, Makowka L, Dindzans V, Falk R, Levy G. Abecassis M, et al. Transplant Proc. 1987 Feb;19(1 Pt 2):1214-7. Transplant Proc. 1987. PMID: 3029911 No abstract available.

10

16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Abecassis M, Falk JA, Makowka L, Dindzans VJ, Falk RE, Levy GA. Abecassis M, et al. J Clin Invest. 1987 Sep;80(3):881-9. doi: 10.1172/JCI113147. J Clin Invest. 1987. PMID: 3624490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters